EcoDrugPlus

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSBSLG00000022537
Gene Symbol: EZH2
3 Cross references
240 Possible Orthologues:

Ephrin Type-B Receptor 4-Like

Ensembl ID : ENSBSLG00000002248
Gene Symbol: LOC114846765
3 Cross references
168 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSBSLG00000018837
Gene Symbol: EGFR
3 Cross references
212 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSBSLG00000005936
Gene Symbol: EPHX2
3 Cross references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSBSLG00000005326
Gene Symbol: ERBB2
3 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSBSLG00000021569
Gene Symbol: ERBB4
3 Cross references
222 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSBSLG00000025188
Gene Symbol: ESR1
3 Cross references
215 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSBSLG00000008098
Gene Symbol: LOC114848155
3 Cross references
207 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSBSLG00000017075
Gene Symbol: LOC114849314
3 Cross references
200 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSBSLG00000006421
Gene Symbol: ESRRG
3 Cross references
203 Possible Orthologues:

Exportin 1

Ensembl ID : ENSBSLG00000017320
Gene Symbol: XPO1
3 Cross references
217 Possible Orthologues:

Exportin 1

Ensembl ID : ENSBSLG00000012551
Gene Symbol: XPO1
3 Cross references
229 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).